This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Oct;12(9):653-68.

doi: 10.1007/BF03350030.

Hyperprolactinemia: neuroendocrine and diagnostic aspects

F Camanni¹, E Ciccarelli, E Ghigo, E E Müller

Affiliations

PMID: 2685096
DOI: 10.1007/BF03350030

Review

Hyperprolactinemia: neuroendocrine and diagnostic aspects

F Camanni et al. J Endocrinol Invest. 1989 Oct.

. 1989 Oct;12(9):653-68.

doi: 10.1007/BF03350030.

Authors

F Camanni¹, E Ciccarelli, E Ghigo, E E Müller

Affiliation

¹ Dipartimento di Fisiopatologia clinica, Università di Torino, Italy.

PMID: 2685096
DOI: 10.1007/BF03350030

No abstract available

PubMed Disclaimer

Similar articles

Neuroendocrine causes of amenorrhea--an update.
Fourman LT, Fazeli PK. Fourman LT, et al. J Clin Endocrinol Metab. 2015 Mar;100(3):812-24. doi: 10.1210/jc.2014-3344. Epub 2015 Jan 12. J Clin Endocrinol Metab. 2015. PMID: 25581597 Free PMC article. Review.
[Neuroendocrine and neurovegetative evaluation of alcoholic patients: initial experiences].
Camerlingo M, Franceschi M, Cicoira U, Aillon C, Gambaro P, D'Alessandro G, Bottacchi E, Perego L, Mamoli A. Camerlingo M, et al. Riv Neurobiol. 1983 Apr-Sep;29(2-3):280-90. Riv Neurobiol. 1983. PMID: 6678015 Italian. No abstract available.
[Neuroendocrine dysfunctions during psychopharmacological treatment: clinical presentations, diagnosis, risk factors and treatment].
Gorobets LN, Mazo GE. Gorobets LN, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):122-30. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 25632425 Review. Russian.
[Current problems in hyperprolactinemia. I. Physiopathology, clinical features, diagnosis and treatment].
Leal-Cerro A, García-Luna PP, Astorga Jiménez R. Leal-Cerro A, et al. Med Clin (Barc). 1987 Jun 6;89(2):76-82. Med Clin (Barc). 1987. PMID: 3302563 Review. Spanish. No abstract available.
[Functional interrelations of monoamines, thyrotropic hormone and thyroid hormones in hyperprolactinemia].
Shikaeva FV, Koreneva GP. Shikaeva FV, et al. Probl Endokrinol (Mosk). 1987 Jul-Aug;33(4):27-30. Probl Endokrinol (Mosk). 1987. PMID: 2889207 Russian.

See all similar articles

Cited by

Control of prolactin secretion.
Benker G, Jaspers C, Häusler G, Reinwein D. Benker G, et al. Klin Wochenschr. 1990 Dec 4;68(23):1157-67. doi: 10.1007/BF01815271. Klin Wochenschr. 1990. PMID: 2126309 Review.
Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.
Grottoli S, Razzore P, Arvat E, Oleandri SE, Rossetto R, Ciccarelli E, Camanni F, Ghigo E. Grottoli S, et al. J Endocrinol Invest. 1997 Nov;20(10):597-602. doi: 10.1007/BF03346916. J Endocrinol Invest. 1997. PMID: 9438917
Diagnosis and drug therapy of prolactinoma.
Ciccarelli E, Camanni F. Ciccarelli E, et al. Drugs. 1996 Jun;51(6):954-65. doi: 10.2165/00003495-199651060-00004. Drugs. 1996. PMID: 8736617 Review.

References

1. J Clin Endocrinol Metab. 1982 Dec;55(6):1118-23 - PubMed
1. Am J Med. 1981 Dec;71(6):961-6 - PubMed
1. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1902-6 - PubMed
1. J Endocrinol. 1972 Apr;53(1):1-15 - PubMed
1. Clin Endocrinol (Oxf). 1981 Aug;15(2):165-74 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer